This patent covers a model of HIV infection. Specifically HIV infected stem cells of the hematopoietic type are infected and infection remains latent. HIV treatments may be assessed using this model of "stem cell" HIV infection.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.